Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

FDA grants orphan drug designation to Pulmatrix's PUR-1900

Aug. 18, 2016

Symbiomix Therapeutics accelerates commercial launch for Solosec

Aug. 18, 2016

Study adds to complexity of nasal flu vaccine picture

Aug. 17, 2016

Japan Tobacco seeks Japanese approval for emtricitabine/tenofovir alafenamide

Aug. 17, 2016

Eiger initiates phase II trial of pegylated interferon lambda for chronic HDV infection

Aug. 17, 2016

Trek Therapeutics in-licenses rights to Medivir's MIV-802

Aug. 17, 2016

Sanofi announces public dengue immunization program in Brazil with Dengvaxia

Aug. 16, 2016

Novadigm Therapeutics discloses positive data from phase IIa trial

Aug. 16, 2016

Novel DNA vaccines provide enhanced protection from Pseudomonas aeruginosa in mice

Aug. 16, 2016

Wockhardt reports beta-lactamase inhibitors

Aug. 12, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...